DOHH and ischemic stroke: Moreover, the identification of deoxyhypusine hydroxylase (DOHH) as a novel pharmacological target for ischemic stroke, with the natural compound brazilin showing strong binding affinity and neuroprotective effects, opens new paths for drug design aimed at enhancing DOHH activity to reduce ischemic neuronal injury.